AbbVie’s Venclexta granted full US approval in AML
admin 19th October 2020 Uncategorised 0FDA approved therapy for newly-diagnosed acute myeloid leukaemia patients More: AbbVie’s Venclexta granted full US approval in AML Source: News
read moreFDA approved therapy for newly-diagnosed acute myeloid leukaemia patients More: AbbVie’s Venclexta granted full US approval in AML Source: News
read moreChief executive of trade body warns no-deal could affect medicines supply More: ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’ Source: News
read moreDupixent, Forxiga and Opdivo were also recommended for therapeutic extensions More: Ten new medicines backed for EU approval Source: News
read morePfizer CEO, facing pushback, shifts COVID-19 vaccine timeline to late November aliu Fri, 10/16/2020 – 11:50 More: Pfizer CEO, facing pushback, shifts COVID-19 vaccine timeline to late November Source: fierce
read moreMerck CEO calls on private industry to ‘stabilize society’ amid racial injustice, economic downturn kblankenship Fri, 10/16/2020 – 11:00 More: Merck CEO calls on private industry to 'stabilize society' amid racial injustice, economic downturn Source: fierce
read moreNIH launches COVID-19 test of J&J, Bristol Myers and AbbVie anti-inflammatory drugs aliu Fri, 10/16/2020 – 10:34 More: NIH launches COVID-19 test of J&J, Bristol Myers and AbbVie anti-inflammatory drugs Source: fierce
read more© 1994 - 2024 B.M. Pharmaceuticals